Atb Cap Markets Forecasts Increased Earnings for Organigram

Organigram Holdings Inc. (TSE:OGI) – Analysts at Atb Cap Markets raised their FY2024 earnings estimates for Organigram in a report released on Sunday, December 8th. Atb Cap Markets analyst F. Gomes now anticipates that the company will earn ($0.33) per share for the year, up from their prior forecast of ($0.34). The consensus estimate for Organigram’s current full-year earnings is $0.16 per share.

Separately, Canaccord Genuity Group decreased their price objective on Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating for the company in a report on Monday.

Organigram Trading Down 0.5 %

TSE OGI opened at C$2.16 on Wednesday. Organigram has a 1 year low of C$1.61 and a 1 year high of C$3.95. The company has a debt-to-equity ratio of 1.13, a current ratio of 6.95 and a quick ratio of 2.62. The company has a market capitalization of C$234.51 million, a PE ratio of -0.86, a P/E/G ratio of 0.42 and a beta of 1.13. The company has a fifty day moving average of C$2.29 and a 200 day moving average of C$2.31.

Insider Activity at Organigram

In other Organigram news, Senior Officer Paolo De Luca sold 12,014 shares of the firm’s stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of C$2.52, for a total value of C$30,275.28. Company insiders own 31.32% of the company’s stock.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.